Johanna Furrer

Johanna Furrer

Auto-generated profile, based on publicly available information

Johanna Furrer

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in EMBO Reports
Verified
Journal Article
Open access
PDF file
PRPierre De Rossi
Pierre De Rossi
ALAmanda J Lewis
Amanda J Lewis
JFJohanna Furrer
Johanna Furrer
LVLaura De Vos
Laura De Vos
TDTomas Demeter
Tomas Demeter
MPMagdalini Polymenidou
Magdalini Polymenidou
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

8 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
VBViktor Beilmann
Viktor Beilmann
JFJohanna Furrer
Johanna Furrer
SSSina M. Schalbetter
Sina M. Schalbetter
RSRon Schaer
Ron Schaer
ETEdoardo Tiziani
Edoardo Tiziani
TNTina Notter
Tina Notter
Astrocytes play critical roles in neural circuit function, but how they contribute to cognitive impairment remains poorly understood. Here, we identify astrocyte-derived kynurenic acid (KYNA), a neuroactive metabolite known to modulate multiple neurotransmitter receptor systems, including the N-methyl-D-aspartate receptor (NMDA), as a mediator of cognitive dysfunction in the context of aberrant astrocyte activity. Using chemogenetic stimulation, pharmacological rescue, and astrocyte-specific knockdown of kynurenine aminotransferase II (KAT II) in mice, we show that elevated KYNA suppresses parvalbumin-positive interneuron activity in the prefrontal cortex, leading to disinhibition of pyramidal neurons and impairments in cognitive functions linked to cortical activity, including episodic-like and working memory as well as sensorimotor gating. These findings define an astrocyte-KYNA-interneuron axis that controls cortical excitability and cognition, linking glial metabolism to circuit imbalance and cognitive dysfunction with potential relevance to psychiatric and neurological disorders.

30 December 2025 in Research Square
Verified
Preprint
Open access
TNTina Notter
Tina Notter
VBViktor Beilmann
Viktor Beilmann
JFJohanna Furrer
Johanna Furrer
SSSina Schalbetter
Sina Schalbetter
RSRon Schaer
Ron Schaer
BWBruno Weber
Bruno Weber
Astrocytes play critical roles in neural circuit function, but how they contribute to cognitive impairment remains poorly understood. Here, we identify astrocyte-derived kynurenic acid (KYNA), a neuroactive metabolite acting as endogenous N-methyl-D-aspartate receptor (NMDA) receptor antagonist, as a key mediator of cognitive dysfunction in the context of aberrant astrocyte activity. Using chemogenetic stimulation, pharmacological rescue, and astrocyte-specific knockdown of kynurenine aminotransferase II (KAT II), we show that elevated KYNA suppresses parvalbumin-positive interneuron activity in the prefrontal cortex, leading to disinhibition of pyramidal neurons and impairments in cognitive functions linked to cortical activity, including episodic-like and working memory as well as sensorimotor gating. These findings define an astrocyte-KYNA-interneuron axis that controls cortical excitability and cognition, linking glial metabolism to circuit imbalance and cognitive dysfunction with broad relevance to psychiatric and neurological disorders.

21 November 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
SSSina-Maria Schalbetter
Sina-Maria Schalbetter
UWUlrike Weber-Stadlbauer
Ulrike Weber-Stadlbauer
KFKim Ferrari
Kim Ferrari
FMFlavia Mueller
Flavia Mueller
RARene Amport
Rene Amport
TNTina Notter
Tina Notter